Determinants of Use of Biotherapeutics in sub-Saharan Africa.

Africa South of the Sahara Delivery of Health Care Humans Noncommunicable Diseases
biologic medicines healthcare delivery sub-Saharan Africa

Journal

Trends in pharmacological sciences
ISSN: 1873-3735
Titre abrégé: Trends Pharmacol Sci
Pays: England
ID NLM: 7906158

Informations de publication

Date de publication:
02 2021
Historique:
received: 01 07 2020
revised: 24 11 2020
accepted: 24 11 2020
pubmed: 29 12 2020
medline: 1 9 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Biologic drugs are reshaping clinical practice in various disciplines, even while access to them is imbalanced across global settings. In sub-Saharan Africa, biotherapeutics have potential roles to play in the treatment of a range of conditions that include infectious and noncommunicable diseases (NCDs). However, the literature is scarce on guidance for addressing local access challenges, including technical, regulatory, affordability, and other healthcare delivery aspects. This article aims to assess fundamental determinants of use of biologic medicines in sub-Saharan Africa. The purpose is to inform strategic actions of scientists, physicians, policymakers, and other stakeholders that are working to improve access to innovative therapies in low resource parts of the world.

Identifiants

DOI: 10.1016/j.tips.2020.11.012 PMID: 33358177
pubmed: 33358177
pii: S0165-6147(20)30267-4
doi: 10.1016/j.tips.2020.11.012
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-84

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Rajiv Shah (R)

Global Health and Corporate Responsibility, Novartis, Basel, Switzerland.

Dzifa Dey (D)

Rheumatology Unit, Department of Medicine and Therapeutics, Korle-bu Teaching Hospital, University of Ghana Medical School, Accra, Ghana.

Thomas Pietzonka (T)

Novartis Institutes for BioMedical Research, Basel, Switzerland.

Paul Obeng (P)

Department of Haematology/Oncology and Paediatric Clinical Pharmacy at Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Bisola Ashiru (B)

Global Drug Development, Novartis, Basel, Switzerland.

Martin Schiestl (M)

Sandoz, Novartis, Langkampfen, Austria.

Andrew Cavey (A)

Global Drug Development, Novartis, Basel, Switzerland.

Edwin Nkansah (E)

Biological Products Department, Food and Drugs Authority (FDA), Accra, Ghana.

Guerric Radiere (G)

Sandoz, Novartis,, Holzkirchen, Germany.

Jonathan Spector (J)

Novartis Institute for Tropical Diseases, Cambridge, MA, USA. Electronic address: jonathan.spector@novartis.com.

Christiaan Scott (C)

Department of Paediatric Rheumatology, University of Cape Town and the Red Cross War Memorial Children's Hospital, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Determinants of Use of Biotherapeutics in...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Determinants of Use of Biotherapeutics in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Determinants of Use of Biotherapeutics in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies non transmissibles › Determinants of Use of Biotherapeutics in...